With 825 Rare Diseases related patents published between 2002 and 2022, Pfizer Inc holds the most number of Rare Diseases patents in Azerbaijan.
The second largest number of Rare Diseases related patents were published by Johnson & Johnson with 730 patents, of which 56.6% was contributed by its subsidiary Janssen Pharmaceutica NV. The third largest number of Rare Diseases related patents were published by Novartis AG with 540 patents, of which 64.6% was contributed by its subsidiary Novartis International Pharmaceutical AG. The fourth largest number of Rare Diseases related patents were published by C. H. Boehringer Sohn AG & Co KG with 524 patents, of which 94.7% was contributed by Boehringer Ingelheim International GmbH. The fifth largest number of Rare Diseases related patents were published by Sanofi with 387 patents, of which 31.5% was contributed by its subsidiary Sanofi-Aventis SA.
The top five patent holders, i.e., Pfizer Inc, Johnson & Johnson, Novartis AG, C. H. Boehringer Sohn AG & Co KG, and Sanofi, together held 3,006 Rare Diseases patents during the period.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward